304am永利集团|·主頁(歡迎您)
About Henlius
Company Profile
Corporate Culture
Honor
Board of Directors
Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
Science & Technology
R&D Result
Innovation Centre
Technology Platform
Quality Management
Manufacturing
Collaborations
Investor Relations
Information Disclosure
Corporate Governance
Financial Reports
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Media
Press Release
Multi-media
Media Reports
Media Enquiry
Careers
Talent Philosophy
Staff Life
Training and Development
Job Opportunities
Contact Us
Contact Information
Customer Message
Privacy
Legal Statement
Compliance
EN
简体
EN
繁體
Home
About Henlius
Company Profile
Corporate Culture
Honor
Board of Directors
Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
Science & Technology
R&D Result
Innovation Centre
Technology Platform
Quality Management
Manufacturing
Collaborations
Investor Relations
Information Disclosure
Listing Documents
Announcement & Circulars
Corporate Governance
Financial Reports
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Media
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
Event
Popular Science
Media Reports
Media Enquiry
Careers
Talent Philosophy
Staff Life
Training and Development
Job Opportunities
Contact Us
Contact Information
Customer Message
Privacy
Legal Statement
Compliance
Technical Innovation Operational Excellence
Information Disclosure
Announcement & Circulars
Listing Documents
Corporate Governance
Board of Directors
Committees
Others
Reporting
Financial Reports
ESG Report
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Investor Presentation
26 August 2024
Henlius 1H24 Results Investor Presentation
21 March 2024
Henlius 2023 Annual Results
15 November 2023
Henlius 3Q23 Results Investor Presentation
25 August 2023
Henlius 1H23 Results Investor Presentation
31 March 2023
Henlius 2022 Annual Results
18 August 2022
Henlius 1H22 Results Investor Presentation
16 March 2022
Henlius 2021 Annual Results
18 August 2021
Henlius 1H21 Results Investor Presentation
26 March 2021
Henlius 2020 Annual Results
30 September 2020
Henlius Recent Business Update
24 August 2020
Henlius 1H20 Results Investor Presentation
13 June 2020
Henlius Global R&D Day
24 April 2020
Henlius HLX02(trastuzumab) EU GMP approval
